Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect and Dosage Form Comparison Study of TAS-118
jRCT2080222329Phase 1
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of S-1 + leucovorin in Nonhematologic neoplasms (2 cohorts), sponsored by Taiho Pharmaceutical Co., Ltd. Primary endpoints: Food effect on TAS-118 pharmacokinetics and Dosage form comparison of TAS-118 vs S-1/LV pharmacokinetics.
02
Drugs
S-1 + leucovorin
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on jRCT2080222329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222329.